Anthera Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US03674U3005

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Brian Mueller. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Brian Mueller telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:BMRN / BioMarin Pharmaceutical Inc. EVP, Chief Financial Officer 99,781
US:ANTH / Anthera Pharmaceuticals, Inc. Director 84,705
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Brian Mueller. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam ANTH / Anthera Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di ANTH / Anthera Pharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ANTH / Anthera Pharmaceuticals, Inc. Insider Trades
Penjualan Orang Dalam ANTH / Anthera Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di ANTH / Anthera Pharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ANTH / Anthera Pharmaceuticals, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Brian Mueller sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-03-18 2025-03-17 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 16,640 99,781 20.01
2025-03-18 2025-03-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -18,497 83,141 -18.20 69.44 -1,284,432 5,773,311
2025-02-27 2025-02-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9,367 101,638 10.15
2025-02-27 2025-02-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9,660 92,271 11.69
2025-02-27 2025-02-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 11,040 82,611 15.43
2024-07-01 2024-06-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -588 71,571 -0.81 82.33 -48,410 5,892,440
2024-05-31 2024-05-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -5,000 72,159 -6.48 75.19 -375,950 5,425,635
2024-05-31 2024-05-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 5,000 77,159 6.93 63.10 315,500 4,868,733
2024-05-31 2024-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 300 72,159 0.42 68.65 20,594 4,953,427
2024-03-19 2024-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -20,789 71,859 -22.44 83.87 -1,743,573 6,026,814
2024-03-19 2024-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 11,400 92,648 14.03
2024-02-29 2024-02-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 6,103 81,248 8.12
2024-02-29 2024-02-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 8,802 75,145 13.27
2024-02-29 2024-02-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 20,220 66,343 43.84
2024-02-12 2023-04-28 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 318 46,123 0.69 66.88 21,267 3,084,614
2023-06-30 2023-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -576 45,805 -1.24 88.93 -51,224 4,073,439
2023-06-30 2023-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -4,602 46,381 -9.03 88.93 -409,256 4,124,662
2023-06-30 2023-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -4,602 46,381 -9.03 88.93 -409,256 4,124,662
2023-03-17 2023-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -3,973 55,585 -6.67 93.41 -371,118 5,192,195
2023-03-17 2023-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -2,708 59,558 -4.35 87.74 -237,600 5,225,619
2023-03-17 2023-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9,630 62,266 18.30
2023-03-02 2023-02-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 1,250 52,636 2.43
2023-03-02 2023-02-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 10,980 51,386 27.17
2023-03-02 2023-02-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 12,660 40,406 45.63
2023-01-17 2023-01-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,500 27,746 -8.27 114.50 -286,250 3,176,917
2023-01-17 2023-01-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,500 30,246 9.01 63.10 157,750 1,908,523
2022-12-15 2022-12-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,500 27,746 -8.27 107.50 -268,750 2,982,695
2022-12-15 2022-12-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,500 30,246 9.01 63.10 157,750 1,908,523
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -3,761 27,746 -11.94 104.50 -393,024 2,899,457
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 3,761 31,507 13.56 67.81 255,033 2,136,490
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,139 27,746 -7.16 104.50 -223,526 2,899,457
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,139 29,885 7.71 67.81 145,046 2,026,502
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -1,101 27,746 -3.82 104.50 -115,054 2,899,457
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -3,500 28,847 -10.82 99.50 -348,250 2,870,276
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 3,500 32,347 12.13 67.81 237,335 2,193,450
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -945 28,847 -3.17 99.50 -94,028 2,870,276
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -934 29,792 -3.04 95.09 -88,814 2,832,921
2022-08-09 2022-08-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -3,500 30,726 -10.23 94.50 -330,750 2,903,607
2022-08-09 2022-08-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 3,500 34,226 11.39 67.81 237,335 2,320,865
2022-07-12 2022-07-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -7,337 30,726 -19.28 89.50 -656,662 2,749,977
2022-07-01 2022-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -576 38,063 -1.49 83.92 -48,338 3,194,247
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -9,762 0 -100.00
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -2,038 0 -100.00
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -9,762 38,639 -20.17 84.50 -824,889 3,264,996
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 9,762 48,401 25.26 37.46 365,685 1,813,101
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,038 38,639 -5.01 84.50 -172,211 3,264,996
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,038 40,677 5.27 37.46 76,343 1,523,760
2022-05-06 2022-04-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 340 38,639 0.89 62.41 21,218 2,411,344
2022-03-17 2022-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -582 38,299 -1.50 80.72 -46,979 3,091,495
2022-03-17 2022-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 26,520 26,520
2022-03-17 2022-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -1,868 38,881 -4.58 78.27 -146,208 3,043,216
2022-03-17 2022-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 11,040 40,749 37.16
2022-02-07 2022-02-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -1,072 29,709 -3.48 87.77 -94,089 2,607,559
2021-06-30 2021-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -576 30,781 -1.84 83.46 -48,073 2,568,982
2021-05-11 2021-05-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -6,709 0 -100.00
2021-05-11 2021-05-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -6,709 31,357 -17.62 79.50 -533,366 2,492,882
2021-05-11 2021-05-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 6,709 38,066 21.40 28.23 189,395 1,074,603
2021-05-11 2021-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 341 31,357 1.10 62.41 21,281 1,956,896
2021-04-02 2021-04-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -5,692 31,016 -15.51 76.30 -434,300 2,366,521
2021-03-23 2021-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -516 36,708 -1.39 78.52 -40,516 2,882,312
2021-03-17 2021-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -582 37,224 -1.54 77.21 -44,936 2,874,065
2021-03-17 2021-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 24,890 24,890
2021-03-17 2021-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -994 37,806 -2.56 78.39 -77,920 2,963,612
2021-03-17 2021-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 10,110 38,800 35.24
2021-02-12 2020-10-30 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 17 29,761 0.06 62.59 1,064 1,862,622
2021-02-04 2021-02-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -1,071 28,673 -3.60 82.82 -88,700 2,374,698
2020-06-30 2020-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 13,230 13,230
2020-06-30 2020-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,640 29,744 18.48
2020-06-30 2020-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 323 25,104 1.30 62.59 20,215 1,571,159
2020-03-24 2020-03-20 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -414 24,781 -1.64 73.05 -30,243 1,810,252
2020-03-17 2020-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 9,600 9,600
2020-03-17 2020-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 6,730 25,195 36.45
2020-03-17 2020-03-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -1,303 18,465 -6.59 84.50 -110,104 1,560,292
2020-02-04 2020-02-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5,800 19,768 41.52
2020-02-04 2019-10-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9 13,968 0.06 62.23 560 869,215
2019-06-07 2019-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 299 13,959 2.19 68.78 20,566 960,128
2019-04-09 2019-04-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,953 13,660 -17.78 94.00 -277,582 1,284,040
2019-03-26 2019-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -415 16,613 -2.44 88.05 -36,541 1,462,775
2019-03-19 2019-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 9,650 9,650
2019-03-19 2019-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5,780 17,028 51.39
2019-03-19 2019-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -1,149 11,248 -9.27 94.53 -108,615 1,063,273
2018-12-20 2018-10-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 22 12,397 0.18 68.78 1,513 852,690
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -782 6,709 -10.44
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -1,718 0 -100.00
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,500 12,375 -16.81 104.50 -261,250 1,293,188
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 782 14,875 5.55 28.23 22,076 419,921
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 1,718 14,093 13.88 28.23 48,499 397,845
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -2,491 1,718 -59.18
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,491 12,375 -16.76 99.50 -247,854 1,231,312
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,491 14,866 20.13 28.23 70,321 419,667
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -654 12,375 -5.02 99.50 -65,073 1,231,312
2018-06-18 2018-06-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,021 13,029 -13.43 94.50 -190,984 1,231,240
2018-06-06 2018-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -346 15,050 -2.25 92.07 -31,856 1,385,654
2018-05-14 2018-05-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,450 15,396 -13.73 89.50 -219,275 1,377,942
2018-05-14 2018-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 287 17,846 1.63 68.78 19,740 1,227,484
2018-03-26 2018-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -414 17,559 -2.30 81.36 -33,683 1,428,600
2018-03-20 2018-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -346 12,263 -2.74 84.10 -29,099 1,031,318
2018-03-20 2018-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 9,120 9,120
2018-03-20 2018-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5,710 17,973 46.56
2018-03-20 2018-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -309 12,609 -2.39 83.57 -25,823 1,053,734
2018-02-14 2017-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 33 12,918 0.26 69.78 2,303 901,379
2018-01-09 2018-01-05 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 84,705 84,705
2018-01-09 2018-01-05 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 84,705 84,705
2017-06-23 2017-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -2,671 0 -100.00
2017-06-23 2017-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,671 12,885 -17.17 100.00 -267,100 1,288,500
2017-06-23 2017-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,671 15,556 20.73 21.51 57,453 334,610
2017-06-06 2017-06-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -376 12,885 -2.84 90.72 -34,111 1,168,927
2017-05-17 2017-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -207 13,261 -1.54 91.50 -18,940 1,213,382
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X -2,600 2,671 -49.33
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,600 13,468 -16.18 93.17 -242,242 1,254,814
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,600 16,068 19.31 21.51 55,926 345,623
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -4,882 13,468 -26.60 91.17 -445,092 1,227,878
2017-05-10 2017-04-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 270 18,350 1.49 70.30 18,982 1,290,078
2017-03-24 2017-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 7,740 7,740
2017-03-24 2017-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,790 18,080 36.04
2017-03-17 2017-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -376 13,290 -2.75 90.96 -34,201 1,208,858
2017-03-17 2017-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -336 13,666 -2.40 92.50 -31,080 1,264,105
2017-02-14 2016-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 62 14,002 0.44 68.42 4,242 958,045
2016-08-03 2016-08-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -287 14,260 -1.97 100.00 -28,700 1,426,000
2016-06-07 2016-06-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -376 14,547 -2.52 90.00 -33,840 1,309,230
2016-05-17 2016-05-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -207 14,923 -1.37 82.71 -17,121 1,234,281
2016-05-10 2016-05-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -444 15,130 -2.85 80.80 -35,875 1,222,504
2016-05-10 2016-04-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 327 15,574 2.14 51.26 16,763 798,386
2016-04-29 2016-04-27 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 41,379 41,379
2016-03-17 2016-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -376 15,247 -2.41 80.34 -30,208 1,224,944
2016-03-17 2016-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock
A - Award 7,000 7,000
2016-03-17 2016-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 3,570 15,623 29.62
2016-02-12 2015-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 127 12,053 1.06 51.26 6,510 617,879
2015-12-24 2015-12-23 4 ANTH Anthera Pharmaceuticals Inc
Common stock
M - Exercise 10,000 10,000 2.89 28,900 28,900
2015-12-24 2014-07-29 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
M - Exercise -10,000 2,500 -80.00
2015-06-08 2015-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -522 11,926 -4.19 120.46 -62,880 1,436,606
2015-06-03 2015-05-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -308 12,448 -2.41 125.57 -38,676 1,563,095
2015-05-22 2015-05-21 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 28,846 28,846
2015-05-19 2015-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -207 12,756 -1.60 122.78 -25,415 1,566,182
2015-05-12 2015-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -444 12,963 -3.31 121.66 -54,017 1,577,079
2015-05-12 2015-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 607 13,407 4.74 51.26 31,117 687,290
2015-03-17 2015-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 9,000 9,000
2015-03-17 2015-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,000 12,800 45.45
2015-03-05 2014-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 10,000 10,000
2015-03-05 2014-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,000 8,800 83.33
2015-03-05 2015-03-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -7,000 8,800 -44.30 109.46 -766,210 963,235
2015-03-05 2015-03-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 7,000 15,800 79.55 28.23 197,610 446,034
2015-03-05 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise -7,000 7,491 -48.31
2015-01-02 2014-12-30 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 12,500 12,500
2014-12-03 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise -5,000 14,491 -25.65
2014-12-03 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -5,000 4,593 -52.12 91.82 -459,100 421,729
2014-12-03 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 5,000 9,593 108.86 28.23 141,150 270,810
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise -6,429 0 -100.00
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise -521 0 -100.00
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -6,950 4,593 -60.21 90.25 -627,238 414,518
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 6,429 11,543 125.71 21.51 138,288 248,290
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 521 5,114 11.34 14.39 7,497 73,590
2014-12-02 2014-11-26 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -3,400 4,593 -42.54 88.97 -302,508 408,653
2014-08-04 2014-07-29 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 12,500 12,500
2014-08-04 2014-07-29 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 18,750 18,750
2014-06-03 2014-05-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -297 7,993 -3.58 57.96 -17,214 463,274
2014-05-16 2014-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -207 8,290 -2.44 57.44 -11,890 476,178
2014-05-14 2014-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -282 8,497 -3.21 59.30 -16,723 503,872
2014-05-12 2014-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -444 8,281 -5.09 56.78 -25,210 470,195
2014-05-12 2014-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 498 8,779 6.01 29.69 14,786 260,649
2014-02-13 2013-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 278 8,725 3.29 27.91 7,758 243,475
2013-06-04 2013-05-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -413 8,447 -4.66 62.70 -25,895 529,627
2013-05-17 2013-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 12,900 12,900
2013-05-17 2013-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2,200 8,860 33.03
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise -3,500 6,429 -35.25 21.51 -75,285 138,288
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -3,500 6,660 -34.45 70.33 -246,155 468,398
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 3,500 10,160 52.55 21.51 75,285 218,542
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -1,447 6,660 -17.85 70.41 -101,890 468,961
2013-05-14 2013-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -479 8,924 -5.09 65.32 -31,288 582,916
2013-05-14 2013-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -817 8,107 -9.16 67.68 -55,295 548,682
2013-05-06 2013-05-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise -4,874 521 -90.34
2013-05-06 2013-05-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -7,500 9,403 -44.37 67.11 -503,295 630,998
2013-05-06 2013-05-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 7,500 16,903 79.76 21.51 161,325 363,584
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise -7,500 15,200 -33.04
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -4,457 9,403 -32.16 65.48 -291,858 615,737
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -4,874 13,860 -26.02 65.35 -318,496 905,696
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 4,874 18,734 35.17 14.39 70,137 269,582
2013-05-06 2013-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 581 13,860 4.38 23.20 13,482 321,621
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise -3,605 63,595 -5.36
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise -730 67,200 -1.07
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise -688 67,930 -1.00
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale 2,015 13,279 17.89 59.81 120,510 794,171
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -5,023 15,294 -24.72 59.74 -300,067 913,642
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 3,605 20,317 21.57 14.39 51,876 292,362
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 730 16,712 4.57 17.86 13,038 298,476
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 688 15,982 4.50 38.59 26,550 616,745
2013-02-14 2012-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 548 15,294 3.72 21.76 11,924 332,797
2013-02-14 2012-05-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -290 14,746 -1.93 35.64 -10,336 525,547
2013-02-14 2012-05-12 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -574 15,036 -3.68 38.00 -21,812 571,368
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X -10,312 68,618 -13.06
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X -5,500 78,930 -6.51
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -15,812 15,340 -50.76 50.00 -790,600 767,000
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 10,312 31,152 49.48 38.59 397,940 1,202,156
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 5,500 20,840 35.85 14.39 79,145 299,888
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X -8,000 84,430 -8.66
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -5,500 15,340 -26.39 47.50 -261,250 728,650
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,500 20,840 -10.71 46.00 -115,000 958,640
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 8,000 23,340 52.15 14.39 115,120 335,863
2012-07-11 2012-07-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X -2,500 92,430 -2.63
2012-07-11 2012-07-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,500 15,340 -14.01 42.50 -106,250 651,950
2012-07-11 2012-07-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,500 17,840 16.30 14.39 35,975 256,718
2012-07-05 2012-07-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X -2,770 94,930 -2.84
2012-07-05 2012-07-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X -2,770 15,340 -15.30 40.00 -110,800 613,600
2012-07-05 2012-07-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2,770 18,110 18.06 17.86 49,472 323,445
2012-05-23 2012-05-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units
M - Exercise 150 2,462 6.49
2012-05-23 2012-05-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes -56 15,340 -0.36 37.98 -2,127 582,613
2012-05-23 2012-05-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 150 15,396 0.98
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units
M - Exercise 750 2,612 40.28
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units
M - Exercise 812 3,362 31.84
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 750 15,246 5.17
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 812 14,496 5.93
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -375 97,700 -0.38
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -625 98,075 -0.63 37.50 -23,438 3,677,812
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -4,291 98,700 -4.17
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -417 102,991 -0.40
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -10,000 103,408 -8.82
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
A - Award 11,800 113,408 11.61
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -15,708 13,684 -53.44 37.50 -589,050 513,150
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 375 29,392 1.29 17.89 6,709 525,823
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 625 29,017 2.20 17.89 11,181 519,114
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 4,291 28,392 17.80 17.33 74,363 492,033
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 417 24,101 1.76 17.54 7,314 422,732
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 10,000 23,684 73.08 11.74 117,400 278,050
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,720 13,684 52.66
2012-05-11 2012-04-30 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 664 8,964 8.00 19.35 12,846 173,418
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -375 97,650 -0.38
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -675 98,025 -0.68 37.50 -25,312 3,675,938
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -4,291 98,700 -4.17
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -417 102,991 -0.40
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -10,000 103,408 -8.82
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
A - Award 11,800 113,408 11.61
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -15,708 13,684 -53.44 37.50 -589,050 513,150
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 375 29,392 1.29 17.89 6,709 525,823
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 625 29,017 2.20 17.89 11,181 519,114
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 4,291 28,392 17.80 17.33 74,363 492,033
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 417 24,101 1.76 17.54 7,314 422,732
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 10,000 23,684 73.08 11.74 117,400 278,050
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4,720 13,684 52.66
2012-05-10 2012-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 664 8,964 8.00 19.35 12,846 173,418
2012-02-28 2012-02-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise -5,000 101,608 -4.69
2012-02-28 2012-02-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale -5,000 8,300 -37.59 35.06 -175,325 291,040
2012-02-28 2012-02-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 5,000 13,300 60.24 11.74 58,700 156,142
2012-02-14 2011-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 964 8,300 13.14 13.23 12,750 109,776
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)